Pancreatic cancer mortality in South Africa: A case-control study
DOI:
https://doi.org/10.7196/SAMJ.2024.v114i1.1132Keywords:
Pancreatic cancer, Mortality, Risk factors, epidemiology, AfricaAbstract
Background. There are variations in the numbers of pancreatic cancer deaths reported annually in South Africa (SA). Since pancreatic cancer deaths occurred in SA from 1997 to 2016, the number of cases has hugely increased, and reached 23 581 in both sexes. Sex differences are likely to contribute to the variations in the strength of associations between the risk factors and pancreatic cancer mortality.
Objective. To identify factors associated with an increased risk of pancreatic cancer mortality in SA.
Methods. A matched case-control study with 1:1 matching was conducted using data collected by Statistics SA from 1997 to 2016. Controls were randomly selected to be as similar as possible to the cases, and matched by age, sex and year of death. Conditional logistic regression was used to identify factors associated with pancreatic cancer mortality.
Results. This case-control study comprised a final selection of 23 581 cases (12 171 males and 11 410 females) and 23 581 controls (12 171 males and 11 410 females). A significantly increased risk of pancreatic cancer mortality was observed among males who were managers (odds ratio (OR) 2.99; 95% confidence interval (CI) 1.36 - 6.60; p=0.006) and craft and related trade workers (OR 1.89; 95% CI 1.14 - 3.14; p=0.013). Elevated risks of pancreatic cancer mortality were also found among females who were managers (OR 6.13; 95% CI 1.32 - 28.52; p=0.021), professionals (OR 2.12; 95% CI 1.24 - 3.63; p=0.006), clerical support workers (OR 3.78; 95% CI 1.79 - 7.98; p=0.001) and elementary occupation workers (OR 1.41; 95% CI 0.99 - 2.00; p=0.059). Smoking was significantly associated with pancreatic cancer mortality in females (OR 1.36; 95% CI 1.02 - 1.82; p=0.039). Working in several occupations was associated with an increased risk of pancreatic cancer mortality in males (OR 1.31; 95% CI 1.01 - 1.71; p=0.045) and females (OR 1.66; 95% CI 1.30 - 2.12; p<0.001).
Conclusion. Smoking and certain occupations increased the risk of pancreatic cancer mortality. Further research is needed to evaluate the associations between other extrinsic and intrinsic factors and pancreatic cancer mortality.
References
Arnold M, Abnet CC, Neale RE, et al. Global burden of 5 major types of gastrointestinal cancer. Gastroenterology 2020;159(1):335-349. https://doi.org/10.1053/j.gastro.2020.02.068
Huang J, Lok V, Ngai CH, et al. Worldwide burden of, risk factors for, and trends in pancreatic cancer. Gastroenterology 2021;160(3):744-754. https://doi.org/10.1053/j.gastro.2020.10.007
Ferlay J, Ervik M, Lam F, et al. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer, 2020. https://gco.iarc.fr/today (accessed 28 April 2023).
Mizrahi JD, Surana R, Valle JW, Shroff RT. Pancreatic cancer. Lancet 2020;395(10242):2008-2020. https:// doi.org/10.1016/s0140-6736(20)30974-0
Gheorghe G, Diaconu CC, Ionescu V, et al. Risk factors for pancreatic cancer: Emerging role of viral hepatitis. J Personalised Med 2022;12(1):83. https://doi.org/10.3390/jpm12010083
CoughlinSS,CalleEE,PatelAV,ThunMJ.Predictorsofpancreaticcancermortalityamongalargecohortof United States adults. Cancer Causes Control 2000;11(10):915-923. https://doi.org/10.1023/a:1026580131793 7. Gapstur SM, Jacobs EJ, Deka A, McCullough ML, Patel AV, Thun MJ. Association of alcohol intake with pancreatic cancer mortality in never smokers. Arch Int Med 2011;171(5):444-451. https://doi.org/10.1001/
archinternmed.2010.536
KernanGJ,JiBT,DosemeciM,SilvermanDT,BalbusJ,ZahmSH.Occupationalriskfactorsforpancreatic cancer: A case‐control study based on death certificates from 24 US states. Am J Industrial Med 1999;36(2):260-270. https://doi.org/10.1002/(sici)1097-0274(199908)36:2<260::aid-ajim5>3.0.co;2-p
DhungelB,MurakamiT,GilmourS,IkedaS,WadaK.Occupation-andindustry-specificcancermortality among Japanese women from 1980 to 2015. BMC Pub Health 2022;22(1):2003. https://doi.org/10.1186/ s12889-022-14304-4
Hassan MM, Bondy ML, Wolff RA, et al. Risk factors for pancreatic cancer: Case-control study. Am J Gastroenterol 2007;102(12):2696-2707. https://doi.org/10.1111/j.1572-0241.2007.01510.x
PickleLW,GottliebMS.PancreaticcancermortalityinLouisiana.AmJPublicHealth1980;70(3):256-259.
https://doi.org/10.2105/ajph.70.3.256
Clary T, Ritz B. Pancreatic cancer mortality and organochlorine pesticide exposure in California, 1989 - 1996. Am J Industrial Med 2003;43(3):306-313. https://doi.org/10.1002/ajim.10188
CoughlinSS,CalleEE,TerasLR,PetrelliJ,ThunMJ.Diabetesmellitusasapredictorofcancermortalityin a large cohort of US adults. Am J Epidemiol 2004;159(12):1160-1167. https://doi.org/10.1093/aje/kwh161
Jeppe CY, Smith MD. Transversal descriptive study of xenobiotic exposures in patients with chronic pancreatitis and pancreatic cancer. JOP 2008;9(2):235-239.
Yako YY, Brand M, Smith M, Kruger D. Inflammatory cytokines and angiogenic factors as potential biomarkers in South African pancreatic ductal adenocarcinoma patients: A preliminary report. Pancreatology 2017;17(3):438-444. https://doi.org/10.1016/j.pan.2017.03.003
Collins JJ, Esmen NA, Hall TA. A review and meta‐analysis of formaldehyde exposure and pancreatic cancer. Am J Industrial Med 2001;39(3):336-345. https://doi.org/10.1002/1097-0274(200103)39:3<336::aid- ajim1022>3.0.co;2-k
Weiderpass E, Partanen T, Kaaks R, et al. Occurrence, trends and environmental etiology of pancreatic cancer. Scand J Work Environ Health 1998;24(3):165-174. https://doi.org/10.5271/sjweh.295
Lin RS, Kessler II. A multifactorial model for pancreatic cancer in man: Epidemiologic evidence. JAMA 1981;245(2):147-152. https://doi.org/10.1001/jama.245.2.147
Egeghy PP, Judson R, Gangwal S, et al. The exposure data landscape for manufactured chemicals. Sci Total Environ 2012;414:159-166. https://doi.org/10.1016/j.scitotenv.2011.10.046
SantosAS,MartinsAA,GonçalvesES,MeyerA.MortalityfromselectedcancersamongBrazilianmechanics. Asian Pacific J Cancer Preven 2020;21(6):1779-1786. https://doi.org/10.31557/apjcp.2020.21.6.1779
HansenES.Mortalityofautomechanics:Aten-yearfollow-up.ScandJWorkEnvironHealth1989;15(1):43- 46. https://doi.org/10.5271/sjweh.1883
Zhang Y, Cantor KP, Lynch CF, Zhu Y, Zheng T. Occupation and risk of pancreatic cancer: A population- based case-control study in Iowa. J Occup Environ Med 2005;47(4):392-398. https://doi.org/10.1097/01. jom.0000158707.88801.f5
BoffettaP,StellmanSD,GarfinkelL.DieselexhaustexposureandmortalityamongmalesintheAmerican Cancer Society prospective study. Am J Industrial Med 1988;14(4):403-415. https://doi.org/10.1002/ ajim.4700140405
Partanen T, Kauppinen T, Degerth R, et al. Pancreatic cancer in industrial branches and occupations in Finland. Am J Industrial Med 1994;25(6):851-866. https://doi.org/10.1002/ajim.4700250609
Blair A, Zahm SH, Silverman DT. Occupational cancer among women: Research status and methodologic considerations. Am J Industrial Med 1999;36(1):6-17. https://doi.org/10.1002/(sici)1097- 0274(199907)36:1<6::aid-ajim2>3.0.co;2-f
Singh S, McDonald JT, Ilie G, Adisesh A. An examination of the association between lifetime history of prostate and pancreatic cancer diagnosis and occupation in a population sample of Canadians. PLoS ONE 2020;15(2):e0227622. https://doi.org/10.1371/journal.pone.0227622
Zaitsu M, Kaneko R, Takeuchi T, Sato Y, Kobayashi Y, Kawachi I. Occupational class and male cancer incidence: Nationwide, multicenter, hospital‐based case-control study in Japan. Cancer Med 2019;8(2):795- 813. https://doi.org/10.1002/cam4.1945
Mallin K, Rubin M, Joo E. Occupational cancer mortality in Illinois white and black males, 1979 ‐ 1984, for seven cancer sites. Am J Industrial Med 1989;15(6):699-717. https://doi.org/10.1002/ajim.4700150609
Nam DJ, Oh CM, Ha E, et al. The association of pancreatic cancer incidence with smoking status and smoking amount in Korean men. Epidemiol Health 2022;44:e2022040. https://doi.org/10.4178/epih. e2022040
Ben QW, Liu J, Sun YW, Wang LF, Zou DW, Yuan YZ. Cigarette smoking and mortality in patients with pancreatic cancer: A systematic review and meta-analysis. Pancreas 2019;48(8):985-995. https://doi. org/10.1097/mpa.0000000000001383
GramIT,ParkSY,WilkensLR,leMarchandL,SetiawanVW.Smokingandpancreaticcancer:Asex-specific analysis in the multiethnic cohort study. Cancer Causes Control 2023;34(1):89-100. https://doi.org/10.1007/ s10552-022-01637-z
Molina-Montes E, van Hoogstraten L, Gomez-Rubio P, et al. Pancreatic cancer risk in relation to lifetime smoking patterns, tobacco type, and dose-response relationships. Cancer Epidemiol Biomarkers Preven 2020;29(5):1009-1018. https://doi.org/10.1158/1055-9965.epi-19-1027
WildCP,WeiderpassE,StewartBW.WorldCancerReport:CancerResearchforCancerPrevention.Lyon: International Agency for Research on Cancer, 2020. https://publications.iarc.fr/586 (accessed 30 April 2023).
HaydenJA,vanderWindtDA,CartwrightJL,CôtéP,BombardierC.Assessingbiasinstudiesofprognostic factors. Ann Internal Med 2013;158(4):280-286. https://doi.org/10.7326/0003-4819-158-4-201302190- 00009
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta- analyses: The PRISMA statement. Ann Internal Med 2009;151(4):264-269. https://doi.org/10.1371/journal. pmed.1000097
Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-560. https://doi.org/10.1136/bmj.327.7414.557
Greenland S, Longnecker MP. Methods for trend estimation from summarised dose-response data, with applications to meta-analysis. Am J Epidemiol 1992;135(11):1301-1309. https://doi.org/10.1093/ oxfordjournals.aje.a116237
Downloads
Published
Issue
Section
License
Copyright (c) 2023 M L Nhleko, I Edoka, E Musenge
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Licensing Information
The SAMJ is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
Publishing Rights
Authors grant the Publisher the exclusive right to publish, display, reproduce and/or distribute the Work in print and electronic format and in any medium known or hereafter developed, including for commercial use. The Author also agrees that the Publisher may retain in print or electronic format more than one copy of the Work for the purpose of preservation, security and back-up.
